Literature DB >> 397927

Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and non-encapsulated Cryptococcus neoformans.

K A Laxalt, T R Kozel.   

Abstract

In the presence of serum, whole cells of encapsulated and non-encapsulated Cryptococcus neoformans generated a chemotactic response by neutrophils. Heat inactivation of serum ablated all chemotactic activity. Cryptococcal polysaccharide was not chemotaxigenic. Assays for alternative complement pathway activation such as depletion of alternative complement pathway factor B or electrophoretic conversion of factor B closely paralleled chemotaxis assays. Cells of encapsulated and non-encapsulated C. neoformans activated the alternative complement pathway, whereas cryptococcal polysaccharide was inactive. Failure of the capsular material to activate the alternative pathway was not due to serotype specificity because polysaccharide of several serotypes failed to achieve activation. The results suggest that chemotaxigenesis and alternative complement pathway activation are functions of the yeast cell wall. The results support our proposal that the cryptococcal capsul does not prevent potential opsonins from reaching binding and activation sites at the yeast cell wall or the release of biologically active soluble cleavage products into the surrounding medium; however, cell wall-bound cleavage products remain bound to the cell wall beneath the capsule. Therefore, they are unable to participate as opsonins in phagocytosis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 397927      PMCID: PMC414633          DOI: 10.1128/iai.26.2.435-440.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Tissue changes and tissue diagnosis in cryptococcosis; a study of 26 cases.

Authors:  R D BAKER; R K HAUGEN
Journal:  Am J Clin Pathol       Date:  1955-01       Impact factor: 2.493

2.  Natural host resistance to infection with Cryptococcus neoformans. I. The effect of the properdin system on the experimental disease.

Authors:  H H GADEBUSCH
Journal:  J Infect Dis       Date:  1961 Sep-Oct       Impact factor: 5.226

3.  Histologic response to capsule-deficient Cryptococcus neoformans.

Authors:  S G Farmer; R A Komorowski
Journal:  Arch Pathol       Date:  1973-12

4.  The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection.

Authors:  R D Diamond; J E May; M A Kane; M M Frank; J E Bennett
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

5.  Candida albicans and the chemotaxis of polymorphonuclear neutrophils.

Authors:  T J Denning; R R Davies
Journal:  Sabouraudia       Date:  1973-11

6.  Prognostic factors in cryptococcal meningitis. A study in 111 cases.

Authors:  R D Diamond; J E Bennett
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

7.  Haemolytic diffusion plate assays for factors B and D of the alternative pathway of complement activation.

Authors:  A Martin; P J Lachmann; L Halbwachs; M J Hobart
Journal:  Immunochemistry       Date:  1976-04

8.  Activation of the alternative (properdin) pathway of complement by Candida albicans and related species.

Authors:  T L Ray; K D Wuepper
Journal:  J Invest Dermatol       Date:  1976-12       Impact factor: 8.551

9.  Nonencapsulated Variant of Cryptococcus neoformans I. Virulence Studies and Characterization of Soluble Polysaccharide.

Authors:  T R Kozel; J Cazin
Journal:  Infect Immun       Date:  1971-02       Impact factor: 3.441

10.  In vitro phagocytosis and intracellular fate of variously encapsulated strains of Cryptococcus neoformans.

Authors:  T G Mitchell; L Friedman
Journal:  Infect Immun       Date:  1972-04       Impact factor: 3.441

View more
  29 in total

1.  Of mice and men, revisited: new insights into an ancient molecule from studies of complement activation by Cryptococcus neoformans.

Authors:  Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

2.  Variables affecting production of monocyte chemotactic factor 1 from human leukocytes stimulated with Cryptococcus neoformans.

Authors:  S M Levitz; E A North; Y Jiang; S H Nong; H Kornfeld; T S Harrison
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

3.  In vitro C3 deposition on Cryptococcus capsule occurs via multiple complement activation pathways.

Authors:  Kileen L Mershon-Shier; Alex Vasuthasawat; Kazue Takahashi; Sherie L Morrison; David O Beenhouwer
Journal:  Mol Immunol       Date:  2011-07-01       Impact factor: 4.407

Review 4.  Cryptococcal interactions with the host immune system.

Authors:  Kerstin Voelz; Robin C May
Journal:  Eukaryot Cell       Date:  2010-04-09

5.  Susceptibilities of Cryptococcus neoformans strains to platelet binding in vivo and to the fungicidal activity of thrombin-induced platelet microbicidal proteins in vitro.

Authors:  S Nail; R Robert; F Dromer; A Marot-Leblond; J M Senet
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

6.  Interdependency of interleukin-10 and interleukin-12 in regulation of T-cell differentiation and effector function of monocytes in response to stimulation with Cryptococcus neoformans.

Authors:  C Retini; T R Kozel; D Pietrella; C Monari; F Bistoni; A Vecchiarelli
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

7.  Mucorales species activation of a serum leukotactic factor.

Authors:  R S Marx; K R Forsyth; S K Hentz
Journal:  Infect Immun       Date:  1982-12       Impact factor: 3.441

Review 8.  Immunity in cryptococcosis: an overview.

Authors:  R A Fromtling; H J Shadomy
Journal:  Mycopathologia       Date:  1982-03-19       Impact factor: 2.574

9.  Involvement of C3a and C5a in interleukin-8 secretion by human polymorphonuclear cells in response to capsular material of Cryptococcus neoformans.

Authors:  A Vecchiarelli; C Retini; A Casadevall; C Monari; D Pietrella; T R Kozel
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

10.  Mobility of human neutrophils in response to Cryptococcus neoformans cells, culture filtrate antigen, and individual components of the antigen.

Authors:  Z M Dong; J W Murphy
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.